Other
LCM inventory valuation adjustment
Analysis
StatementIncome Statement
SectionOther
Metric ID:
other_inventory_lifo_reserve_period_chargeBusiness Segments
| Segment | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| North American Pharmaceutical | — | — | — | $110M | -$52.5M | -$52.5M | -$52.5M | -$52.5M |
| U.S. Pharmaceutical | -$242M | -$7M | -$10M | $110M | -$52.5M | -$52.5M | -$52.5M | -$52.5M |
| Total | — | — | — | — | — | — | — | — |
U.S. Pharmaceutical was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
